Envoy Medical (COCH) Gross Margin (2022 - 2026)
Envoy Medical (COCH) reported Gross Margin of 702.56% for Q1 2026, down 31126.0% on a YoY basis from N/an in Q1 2025, and down 287.44% sequentially from 181.33% in Q4 2025.
Envoy Medical (COCH) Gross Margin (2022 - 2026) Analysis & Trends
Envoy Medical (COCH) has 5 years of Gross Margin data on file, last reported at 702.56% in Q1 2026.
- For the quarter ending Q1 2026, Gross Margin fell 31126.0% year-over-year to 702.56%; the trailing twelve-month figure through Mar 2026 stood at 310.68% (down 2625.0% YoY), and the FY2025 full-year result was 262.66%, down 3288.0% from the prior year.
- Gross Margin eased to 702.56% in Q1 2026, from 181.33% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 85.96% in Q3 2022 to a low of 702.56% in Q1 2026.
- A 5-year average of 272.73% and a median of 200.0% in 2025 frame the typical range for Gross Margin.
- Across the five-year window, Gross Margin jumped 50868 bps in 2023 and plunged 31126 bps in 2026, its largest moves.
- Tracing COCH's Gross Margin over 5 years: stood at 655.0% in 2022, then soared by 78 bps to 146.32% in 2023, then tumbled by 87 bps to 273.81% in 2024, then soared by 34 bps to 181.33% in 2025, then sank by 287 bps to 702.56% in 2026.
- Business Quant data shows COCH's Gross Margin at 702.56% in Q1 2026, 181.33% in Q4 2025, and 383.33% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 78.01% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 62.95% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 45.22% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 38.53% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Envoy Medical | 45.50 Mn | 20.25 Mn | -274,000.00 | -702.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -702.56% |
| Dec 31, 2025 | -181.33% |
| Sep 30, 2025 | -383.33% |
| Jun 30, 2025 | -200.00% |
| Mar 31, 2025 | -391.30% |
| Dec 31, 2024 | -273.81% |
| Sep 30, 2024 | -233.93% |
| Jun 30, 2024 | -260.29% |
| Mar 31, 2024 | -159.32% |
| Dec 31, 2023 | -146.32% |
| Sep 30, 2023 | -136.25% |
| Jun 30, 2023 | -157.14% |
| Mar 31, 2023 | -124.36% |
| Dec 31, 2022 | -655.00% |
| Sep 30, 2022 | -85.96% |